Of note, IDH1/2 mutated adult AML has been described to drive aberrant perturbations in the tricarboxylic cycle through the reduction of alpha‐ketoglutarate to the oncometabolite 2‐hydroxyglutarate [47]. The gene discussed is IDH1; the disease is acute myeloid leukemia.